Literature DB >> 16008236

Comparison of susceptibility of fungal isolates to lufenuron and nikkomycin Z alone or in combination with itraconazole.

Richard F Hector1, Autumn P Davidson, Suzanne M Johnson.   

Abstract

OBJECTIVE: To evaluate and compare the in vitro antifungal properties of lufenuron and nikkomycin Z against isolates of Coccidioides immitis and Aspergillus fumigatus when used singly and in combination with the azole antifungal agent itraconazole. SAMPLE POPULATION: 3 clinical isolates of A fumigatus and the Silveira strain of C immitis. PROCEDURE: The fungal isolates were tested in vitro for susceptibility to the single and combination of compounds by use of microtiter-format susceptibility methods. Minimum inhibitory concentration end points were determined visually, and the contents of representative wells were examined microscopically for evidence of morphologic effects on fungi.
RESULTS: No evidence of inhibition, either by susceptibility testing or direct microscopic examination of treated cells, was obtained with lufenuron under experimental conditions. In contrast, nikkomycin Z, a known inhibitor of fungal chitin synthesis, had potent activity against C immitis when used singly. A synergistic interaction between nikkomycin Z and itraconazole was found against isolates of both species tested. CONCLUSIONS AND CLINICAL RELEVANCE: On the basis of our in vitro data, lufenuron does not appear to possess antifungal properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008236     DOI: 10.2460/ajvr.2005.66.1090

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination.

Authors:  Patricia E B Verwer; M L van Duijn; M Tavakol; Irma A J M Bakker-Woudenberg; Wendy W J van de Sande
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

2.  Screening for antifungal peptides and their modes of action in Aspergillus nidulans.

Authors:  Daniel Mania; Kai Hilpert; Serge Ruden; Reinhard Fischer; Norio Takeshita
Journal:  Appl Environ Microbiol       Date:  2010-09-10       Impact factor: 4.792

3.  Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.

Authors:  Lisa F Shubitz; Hien T Trinh; Robert H Perrill; C Michael Thompson; Nathan J Hanan; John N Galgiani; David E Nix
Journal:  J Infect Dis       Date:  2014-01-12       Impact factor: 5.226

Review 4.  Fungal endometritis in bovines.

Authors:  Pinki Saini; Madhumeet Singh; Pravesh Kumar
Journal:  Open Vet J       Date:  2019-03-27

5.  Initial Results of the International Efforts in Screening New Agents against Candida auris.

Authors:  Vanice Rodrigues Poester; Lívia Silveira Munhoz; Jéssica Louise Benelli; Aryse Martins Melo; Abdullah M S Al-Hatmi; David J Larwood; Marife Martinez; David A Stevens; Melissa Orzechowski Xavier
Journal:  J Fungi (Basel)       Date:  2022-07-25

Review 6.  Antimicrobial Peptides: a New Frontier in Antifungal Therapy.

Authors:  Giuseppe Buda De Cesare; Shane A Cristy; Danielle A Garsin; Michael C Lorenz
Journal:  mBio       Date:  2020-11-03       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.